PT Charlie Hospital Semarang Tbk (ISX:RSCH) EBITDA Margin %: 0.00% (As of . 20)


What is PT Charlie Hospital Semarang Tbk EBITDA Margin %?

PT Charlie Hospital Semarang Tbk ISX:RSCH -3.68% EBITDA Margin % is 0.00% as of . 20. The stock has 1 warning sign investors should review. Among 665 Healthcare Providers & Services companies, PT Charlie Hospital Semarang Tbk ranks worse than 150375.79% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PT Charlie Hospital Semarang Tbk's EBITDA for the six months ended in . 20 was Rp0.00 Mil. PT Charlie Hospital Semarang Tbk's Revenue for the six months ended in . 20 was Rp0.00 Mil. Therefore, PT Charlie Hospital Semarang Tbk's EBITDA margin for the quarter that ended in . 20 was 0.00%.

PT Charlie Hospital Semarang Tbk  (ISX:RSCH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PT Charlie Hospital Semarang Tbk EBITDA Margin % Related Terms

PT Charlie Hospital Semarang Tbk EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PT Charlie Hospital Semarang Tbk's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Charlie Hospital Semarang Tbk EBITDA Margin % Chart

PT Charlie Hospital Semarang Tbk Annual Data
Trend
EBITDA Margin %

PT Charlie Hospital Semarang Tbk Semi-Annual Data
EBITDA Margin %

ISX:RSCH vs HCA, THC, DVA: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, PT Charlie Hospital Semarang Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Charlie Hospital Semarang Tbk EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Charlie Hospital Semarang Tbk's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PT Charlie Hospital Semarang Tbk's EBITDA Margin % falls into.


PT Charlie Hospital Semarang Tbk EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PT Charlie Hospital Semarang Tbk's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

PT Charlie Hospital Semarang Tbk's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. According to the industry distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 665 companies in the Healthcare Providers & Services industry.
Is PT Charlie Hospital Semarang Tbk's EBITDA Margin % too high?
PT Charlie Hospital Semarang Tbk's current EBITDA Margin % is 0.00%. Based on the distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does PT Charlie Hospital Semarang Tbk's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Charlie Hospital Semarang Tbk ranks #999999 out of 665 companies for EBITDA Margin %. This places PT Charlie Hospital Semarang Tbk in the lower half of its industry. The industry median EBITDA Margin % is 10.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Charlie Hospital Semarang Tbk's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Charlie Hospital Semarang Tbk stock overvalued right now?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Charlie Hospital Semarang Tbk (ISX:RSCH), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Charlie Hospital Semarang Tbk Business Description

Address Raya Ngabean Road, Lot 1A, Ngabean Village, Boja District, Kendal Regency, Central Java, Jawa, IDN, 51381
PT Charlie Hospital Semarang Tbk is engaged in private hospital activities with type D hospital qualifications located in Kendal Regency. It provides medical facilities, such as a 24-hour emergency room, Specialist Polyclinic services, Central Surgical Installation, Intensive Care Unit (ICU), Perina, Laboratory, Radiology, Pharmacy, and other supporting facilities. It operates in three segments, namely Hospital service consist of medical goods and services provided to out patients and inpatients. Construction materials trading and Construction activities include services rendered on a fee or contract basis, as well as the construction, maintenance, or reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings.